CLINICAL ROLE -
Brown Bag Consult®: Melanoma
Melanoma is responsible for 80% of skin cancer deaths.
Breaking the Bank: Financial Toxicity in Cancer Care
The increasing economic burden of treatment may impact patient outcomes.
Technology Can Help Navigate Financial Assistance Programs in Specialty Care
The goal of the financial counselor is to identify available funding for patient care in a timely manner, but the sheer number of resources and variables involved results in a long, tedious process.
Principles, Updates in Chemotherapy-Induced Nausea, Vomiting
Chemotherapy-induced nausea and vomiting can impact patients’ treatment outcomes.
Lack of Transparency in 340B Program Leads to Lack of Access for Patients
More transparent drug pricing could improve patient care.
Representation in Oncology Drug Trials Impacts Patient Health
The FDA looks to address a lack of diversity in cancer drug trials.
Current Treatments in Bladder Cancer
Bladder cancer risk increases with age and is more common among men than women.
Home Infusion Technology Use Adapted to the Needs of the COVID-19 Pandemic
Modern technology is crucial to the provision of home infusions.
Self-Management Support in Cancer Care
The cancer care system lags in comparison to other chronic health conditions in this key area.
Marginal Zone Lymphoma: Subtypes, Treatments, the Role of the Pharmacist
Although marginal zone lymphoma is relatively rare, it contains a broad spectrum of conditions under it that require an individualized treatment selection process.
Expert Panel Reviews Recommended Therapy Options for Hodgkin Lymphoma
Experts reviewed the efficacy and safety of the recommended treatment regimens and discussed which treatment strategy they would recommend for their patients.
Targeting the Untargetable: Novel Agents in Acute Myeloid Leukemia
Pharmacists have an important role in the optimization of AML therapies.
Current Drug Pathways in Non–Small Cell Lung Cancer
Advancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.
Facilitating Access to Oncology Medication
Timely access to cancer treatment improves patient outcomes.
Addressing the High Cost of Gene Therapies for Rare Diseases: An SPBM Perspective
As some of the nation’s leading pharmaceutical and biotech giants ramp up product development and commercialization, what was once a futuristic concept has become a reality.
The Road to Optimal Oncology Patient Outcomes Is Paved By Oncology Pharmacists
Oncology pharmacists play a significant role in clinical pathways.
Patient Access in Oncology: An Increasingly Complex Landscape
Underserved populations with limited access to medical care continue to be disproportionately impacted by certain cancers.
